Abstract:Group 3 innate lymphoid cells (ILC3s) are mediators of intestinal immunity and barrier function. Recent studies have investigated the role of the mammalian target of rapamycin complex (mTOR) in ILC3s, whereas the mTORC1-related mechanisms and crosstalk between mTORC1 and mTORC2 involved in regulating ILC3 homeostasis remain unknown. In this study, we found that mTORC1 but not mTORC2 was critical in ILC3 development, IL-22 production, and ILC3-mediated intestinal homeostasis. Single-cell RNA sequencing revealed that mTORC1 deficiency led to disruption of ILC3 heterogeneity, showing an increase in differentiation into ILC1-like phenotypes. Mechanistically, mTORC1 deficiency decreased the expression of NFIL3, which is a critical transcription factor responsible for ILC3 development. The activities of both mTORC1 and mTORC2 were increased in wild-type ILC3s after activation by IL-23, whereas inhibition of mTORC1 by Raptor deletion or rapamycin treatment resulted in increased mTORC2 activity. Previous studies have demonstrated that S6K, the main downstream target of mTORC1, can directly phosphorylate Rictor to dampen mTORC2 activity. Our data found that inhibition of mTORC1 activity by rapamycin reduced Rictor phosphorylation in ILC3s. Reversing the increased mTORC2 activity via heterozygous or homozygous knockout of Rictor in Raptor -deleted ILC3s resulted in severe ILC3 loss and complete susceptibility to intestinal infection in mice with mTORC1 deficiency (100% mortality). Thus, mTORC1 acts as a rheostat of ILC3 heterogeneity, and mTORC2 protects ILC3s from severe loss of cells and immune activity against intestinal infection when mTORC1 activity is diminished.

c-Maf restrains T-bet-driven programming of CCR6-negative group 3 innate lymphoid cells

c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program

c-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host–microbiota homeostasis

c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4+ T cells

T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells

Reciprocal transcription factor networks govern tissue-resident ILC3 subset function and identity

c-Maf Regulates IL-10 Expression during Th17 Polarization

Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s

mTORC2 acts as a gatekeeper for mTORC1 deficiency-mediated impairments in ILC3 development

NFATc1/αA and Blimp-1 Support the Follicular and Effector Phenotype of Tregs

Antibody Fc-receptor FcεR1γ stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity

c-MAF, a Swiss Army Knife for Tolerance in Lymphocytes

Diet-mediated constitutive induction of novel IL-4+ ILC2 cells maintains intestinal homeostasis in mice

CTLA-4-expressing ILC3s restrain interleukin-23-mediated inflammation

Bcl6 and Maf Cooperate To Instruct Human Follicular Helper CD4 T Cell Differentiation

c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont

ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut

Differential metabolic requirement governed by transcription factor c-Maf dictates innate γδT17 effector functionality in mice and humans

CMIP is a negative regulator of T cell signaling

Activation of the Transcription Factor C-Maf in T Cells is Dependent on the CARMA1-IKKβ Signaling Cascade

Blimp-1 and c-Maf regulate immune gene networks to protect against distinct pathways of pathobiont-induced colitis